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Abstract
Stress echocardiography (stress echo), with use of both old and new ultrasonographic car-
diac function imaging techniques, has nowadays become a widely available, safe and inex-
pensive diagnostic method. Cardiac stress, such as exercise or an inotropic agent, allows for 
dynamic assessment of a wide range of functional parameters describing ventricles, heart 
valves and pulmonary circulation. In addition to diagnosis of ischemic heart disease, stress 
echocardiography is also used in patients with acquired and congenital valvular defects, 
hypertrophic cardiomyopathy, dilated cardiomyopathy as well as diastolic and systolic heart 
failure. Physical exercise is the recommended stressor in patients with aortic and especially 
mitral valvular disease. Nevertheless, dobutamine stress echo is useful for the assessment of 
contractile and flow reserve in aortic stenosis with reduced left ventricular ejection fraction. 
Stress echo should always be performed by an appropriately trained cardiologist assisted 
by a nurse or another doctor, in the settings of an adequately equipped echocardiographic 
laboratory and with compliance to safety requirements. Moreover, continuous education of 
cardiologists performing stress echo is needed.
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Introduction
Stress echocardiography (stress echo, SE), with use of both 
old and new ultrasonographic cardiac function imaging 
techniques, has nowadays become a widely available, safe 
and inexpensive diagnostic method. Cardiac stress, such as 
exercise or an inotropic agent, allows for dynamic assess-
ment of a wide array of ventricles, heart valves and pulmo-
nary circulation functional parameters. The registration of 
dynamic cardiac response provides completely new insight 
important from both diagnostic and prognostic point of 
view. In addition to diagnosis of ischemic heart disease, 
stress echocardiography is also used in patients with val-
vular defects, hypertrophic cardiomyopathy, dilated car-
diomyopathy as well as diastolic and systolic heart fail-
ure(1). The protocol for dobutamine stress echo is shown 
in Fig. 1. Low-dose dobutamine stress echo (up to 20 μg/
kg/min) is recommended for patients with low-gradient 
and low-flow aortic stenosis and reduced ejection fraction 
(EF). High-dose dobutamine stress echo (up to 40 μg/kg/
min) is often needed in patients with heart failure treated 
with beta-blockers. Fig. 2 shows stress echo protocol for 
cycle ergometer (examination usually performed in the left 
lateral recumbent position) or treadmill.
A number of echocardiographic parameters may be reg-
istered during the stress echo; in practice, however, the 
assessment is limited to those most important for given 
clinical problem (Tab. 1). The choice of stressor depends 
on clinical scenario (e.g. an evaluation of flow and contrac-
tile reserve only in dobutamine test) and patient’s physi-
cal fitness. Cycle ergometer should be recommended for 
the less fit and elderly patients. Furthermore, it is easier to 
record Doppler parameters using a cycle ergometer than 
a treadmill. Diagnostic end-points, reasons for stress echo 
interruption, and criteria for an abnormal stress echo are 
shown in Tab. 2.
Acquired cardiac valvular diseases
Physical exercise is the recommended stressor in patients 
with aortic (regurgitation, stenosis) and mitral valvular 
defects (regurgitation, stenosis). One should bear in mind 
that especially in the latter ones, where the dynamic influ-
ence of momentarily left ventricular function on the defect 
is of particular significance, the use of dobutamine, which 
is LV function dependent, can alter loading conditions and 
this way may cause difficulty in test results interpretation. 
On the contrary, for the assessment of contractile and flow 
reserve in aortic stenosis, where an increase in the left ven-
tricular stroke volume is of key importance, dobutamine 
stress echo is tremendously useful. The benefits of exercise 
stress in patients with valvular defects along with the basic 
assessment criteria are summarized in Fig. 3. 
Aortic stenosis 
In the case of severe aortic valve stenosis, progressive 
LV pressure overload and/or coexisting ischemic/post-
infarction myocardial damage inevitably lead to reduced 
LV stroke volume and, consequently, reduced flow velocity 
and transvalvular gradient. In this subgroup of patients 
with the so-called classical low-flow low-flow aortic ste-
nosis (defined as EF <50%; mean gradient <40 mm Hg; 
maximum transvalvular flow velocity Vmax <4.0 m/s; aortic 
valve area, AVA <1.0 cm2), differentiation between severe 
(true severe) and moderate (pseudo-severe) aortic steno-
sis, as well as an estimation of LV contractile reserve are 
feasible during dobutamine stress echo. In accordance 
with the protocol, dobutamine dose should be gradually 
increased from 10 to 30 μg/kg/min at 3–5-minute inter-
vals, under continuous monitoring of blood pressure, 
ECG and clinical symptoms (dyspnea, angina pectoris, 
ventricular arrhythmia). Patients with >20% increase 
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Fig. 1.  Dobutamine stress echo protocol and parameters recorded at 
each test stage(1). LV – left ventricle, SV – stroke volume, AVA 
– aortic valve area, BP – blood pressure
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Fig. 2.  Protocol for stress echo (SE) using cycle ergometer or trade-
mill. Parameters recorded at each test stage are shown: MR 
– mitral regurgitation, RV – right ventricle, LV – left ventricle, 
LVOT – left ventricular outflow tract, PB – blood pressure, 
SPAP – systolic pulmonary artery pressure(1)
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rise of the gradient (mean gradient <40 mm Hg), mod-
erate aortic stenosis with preserved flow reserve should 
be diagnosed. Patients with severe stenosis and no flow 
reserve present persistent AVA <1.0 cm2 and lack of SV 
increase (or <20% increase from the resting value) despite 
higher doses (up to 30 μg/kg/min). This subgroup is char-
acterized by worse prognosis compared to patients with 
preserved flow reserve regardless of treatment (conser-
vative or surgical). Doppler technique should be used for 
calculations of both aortic orifice area and LV stroke vol-
ume. Although the role of dobutamine stress echo in the 
diagnosis and the prognosis estimation in patients with 
the so-called paradoxical low-gradient severe stenosis (SV 
<35 mL/m2, EF >50%, mean gradient <40 mm Hg) is 
currently not precisely defined, it may help differentiate 
between true severe and pseudo-severe stenosis(2–4).
Cycle ergometer stress testing may help determine the 
time of surgical/percutaneous intervention (AVR/TAVI) in 
asymptomatic patients with severe aortic stenosis (AVA 
<1.0 cm2, mean transvalvular gradient <40 mm Hg, EF 
>50%). Increased exercise gradient (by >18–20 mm Hg), 
reduced LV contractility, no LV contractile reserve and 
exercise-induced systolic pulmonary artery pressure 
(SPAP) >60 mm Hg may indicate the need for earlier sur-
gical intervention (Fig. 3).
Aortic regurgitation
Cycle ergometer stress test, which is performed to elicit clin-
ical symptoms (exercise dyspnea), as well as to assess exer-
cise tolerance (the level of exercise load) and LV contractile 
reserve, is recommended for patients with asymptomatic 
aortic regurgitation. Defect staging based on exercise and 
dobutamine stress echo is not recommended as increased 
heart rate and reduced diastolic time limit the accuracy of 
quantitative measurement of aortic regurgitation wave. The 
lack of contractile reserve (D EF <5% at peak load) should 
preferably be accompanied with concurrent assessment of 
longitudinal LV strain (tissue Doppler). Thus revealed sub-
clinical LV dysfunction has a documented prognostic value 
and is associated with worse postoperative prognosis. The 
test may help determine true cause of symptoms reported 
by patients with moderate aortic regurgitation as clinical 
manifestation may in fact be related to exercise-induced 
in left ventricular stroke volume (LV SV) due to inotro-
pic stimulation and a simultaneous increase in both the 
flow through the aortic orifice and transvalvular gradient 
(>40 mm Hg) without significant increase in aortic valve 
area (change in AVA by <0.2 cm2, AVA <1,0 cm2) should 
be diagnosed with severe aortic stenosis with preserved 
flow reserve. Alternatively, if the dobutamine-induced SV 
increase (>20% of resting SV) is accompanied by signifi-
cant AVA increase (AVA >1.0 cm2) without simultaneous 
Parameters Threshold values
Left intraventricular 
obstruction LVOT gradient >50 mm Hg 
Impaired functional 
reserve 
∆ WMSI <0.25 in ectatic cardiomyopathy (SE, DE)
∆ EF <7.5% in NS and CRT patients (SE, DE)
∆ EF <4.5% in primary MR and AR (SE)
∆ Global longitudinal strain <2%  
in organic MR (SE) 
Impaired flow reserve ∆ SV <20% (DE) 
Dynamic mitral  
regurgitation ∆  EROA >13 mm
2 in functional MR (SE) 
Systolic pulmonary 
hypertension  SPAP >60 mm Hg (SE) 
Limited valvular 
compliance
 Mean diastolic gradient in mitral stenosis 
 >15 mm Hg (SE); >18 mm Hg (DE)
 Systolic gradient in aortic stenosis >18 mm Hg 
(SE)
Prosthetic  
malfunction 
Mean diastolic gradient in mitral position  
>10 mm Hg (SE, DE)
Mean systolic gradient in aortic position  
>20 mm Hg (SE, DE)
Functional stenosis 
after mitral ring plasty Mean diastolic gradient >7 mm Hg 
RV dysfunction TAPSE <19 mm in limited MR (SE) 
DE – stres echo z dobutaminą, SE – stres echo wysiłkowe, EF – frakcja 
wyrzutowa, SV – objętość wyrzutowa, WMSI – wskaźnik kurczliwości
Tab. 1.  Threshold values of stress echo parameters associated with 
prognosis and treatment response. DE – dobutamine stress 
echo, SE- exercise stress echo, EF – ejection fraction, SV - stro-
ke volume, WMSI – contractility index 
Diagnostic end-points Reasons for test interruption Improper test criteria (>1 criterion)
Maximum dobutamine dose/
maximum exercise Intolerable symptoms 
Symptoms: angina pectoris, dyspnea, syncope, fatigue at low 
stress level 
Target heart rate Muscular fatigue Ischemia (ST drop by >2 mm vs baseline) 
Typical changes in ECG Hypertension (220/120 mm Hg) New disorders of regional contractility 
Typical changes in echocardiogram Symptomatic hypotension(decrease by >40 mm Hg) Arrhythmias (NSVT, SVT)
Retrosternal pain Arrhythmias (SVT, AF, multiple ventricular ectopic beats ) Specific end-points* 
*  Specific end-points refer to threshold values for echo parameters, which are associated with worse prognosis, absence of treatment response (e.g. 
intraventricular gradient> 50 mmHg) – see Tab. 1.
Tab. 2.  Diagnostic end-points and reasons for stress echo interruption
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dynamic mitral regurgitation, pulmonary hypertension or 
left ventricular diastolic dysfunction (Fig. 3).
Mitral regurgitation 
Increasing MR (≥ grade1), dynamic pulmonary hyperten-
sion (SPAP >60 mm Hg), lack of the LV contractile reserve 
(D EF <5%, D longitudinal LV strain <2%), and lack of the 
RV contractile reserve (D TAPSE <19 mm) imply poor prog-
nosis in symptomatic patients with moderate primary mitral 
regurgitation. In case of patients with severe asymptomatic 
primary mitral regurgitation, stress echo should primarily 
focus on possible provocation of clinical symptoms (dys-
pnea), detection of dynamic pulmonary hypertension (SPAP 
>60 mm Hg) and assessment of LV contractile reserve while 
repeated grading of regurgitant flow is not required. 
For functional regurgitation, exercise stress is needed 
when there is a large disproportion between the degree of 
regurgitation at rest and clinical symptoms (positional dys-
pnea, exercise intolerance, recurrent pulmonary edema). 
Cardiac stress test may help decide if planned revascular-
ization (e.g. CABG) should be complemented with mitral 
repair. In these settings, exercise-induced increase in 
ERO by >13 mm2 and exercise pulmonary hypertension 
>60 mm Hg indicate worse prognosis. On the other hand, 
exercise-induced reduction of regurgitation or even its full 
resolution, suggest presence of the contractile reserve and 
better prognosis (Fig. 3).
Mitral stenosis
Stress testing allows for simultaneous analysis of hemo-
dynamic stage and symptoms associated with the defect, 
particularly in patients with disproportion between symp-
toms and resting measurement of orifice area and diastolic 
gradient. Exercise gradient >15 mm Hg (mean gradient) and 
SPAP >60 mm Hg (maximum gradient) signify severe mitral 
stenosis regardless of the area of mitral orifice (Fig. 3).
Prosthetic valves 
In case of patients with implanted prosthetic valves and 
clinical symptoms, stress echo facilitates verification of 
relationship between reported symptoms and prosthetic 
malfunction. Cycle ergometer is the preferred option in 
most patients. Low-dose dobutamine test (up to 20 μg/
kg/min) is performed in patients with moderate-to-severe 
symptoms. 
Cycle ergometer testing allows for diagnosis of valvular 
stenosis or patient-prosthesis mismatch (PPM) in patients 
with mitral or aortic prostheses and mild-to-moderate 
increase in resting transvalvular gradients. Low-dose dobu-
tamine (DE) stress echo allows for differentiation between 
true prosthetic malfunction, prosthetic pseudo-malfunction 
and mismatch in patients with low valvular flow, low rest-
ing effective orifice area (EOA) and decreased Doppler 
velocity index (DVI) (Tab. 1).
Hypertrophic cardiomyopathy 
Exercise stress echo reveals clinical symptoms and allows 
for monitoring of response to treatment in patients with 
hypertrophic cardiomyopathy (HCM). Increased exer-
cise gradient >50 mm Hg, abnormal blood pressure (BP) 
response to exercise, LV systolic and diastolic dysfunction 
(regional contractile disorders, increased E/e’), as well as 
Defect stage (MR, MS, AR) inconsistent
with clinical symptoms
Δ 18–20 mm Hg MPG in AS
Δ MPG >15–18 mm Hg in MS
Δ >10–13 mm2 EROA in MR
Δ <5% LVEF (no contractile reserve)
Δ <2% GLS (no contractile reserve)
Δ SV <20% (no flow reserve)
Δ WMSI (ischemia)
LV dyssynchrony
RV dysfunction (TAPSE <19 mm)
Δ E/e’ (LV filling pressure)
PH (SPAP >60 mm Hg)
Asymptomatic moderate-to-severe defect
(MR, MS, AR)
HemodynamicsVentricle
Symptoms, Δ BP, exercise tolerance
Valve
Determination of the
relationship between
symptoms and valvular defect 
The choice of optimal time
of surgical treatmentRisk stratication
Fig. 3.  The usefulness of stress echo (SE) in the assessment of acquired valvular defects. The following parameters are individually assessed: 
valvular function alone, LV and RV function, and other hemodynamic consequences of the defect(1). MR – mitral regurgitation, MS – 
mitral stenosis, AR – aortic regurgitation, AS – aortic stenosis, SV – stroke volume, MPG - mean pressure gradient, PH – pulmonary 
hypertension
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Stress echo should always be performed by an appropri-
ately trained cardiologist assisted by a nurse or another 
doctor, in the settings of an adequately equipped echo-
cardiographic laboratory and with compliance to safety 
requirements. Moreover, continuous education of cardiolo-
gists performing stress echo is needed(7–9).
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increased dynamic mitral regurgitation are associated with 
worse exercise tolerance and poor prognosis. Exercise stress 
test is contraindicated in patients with gradient >50 mm Hg 
measured during rest or Valsalva maneuver (Tab. 1).
Dilated cardiomyopathy and cardiac 
resynchronization therapy 
Low-dose dobutamine test is helpful for prediction of 
response to cardiac resynchronization therapy (CRT). The 
increase of LVEF by >7%, presence of contractile reserve 
(improved wall motion score index, WMSI) and reduction 
of mitral regurgitation during dobutamine test are the pre-
dictors of advantageous LV remodeling after CRT pace-
maker implantation(5,6).
